Articles  |   October 2018
Anesthesia Patient Safety Foundation Panel on Neuromuscular Blockade and Patient Safety: ‘Assessing and Analyzing the Perceptions of Perioperative Professionals on Neuromuscular Blockade and Residual Neuromuscular Paralysis’
Author Affiliations
  • Mark A. Warner, M.D.
    President, Anesthesia Patient Safety Foundation
Article Information
Neuromuscular Diseases and Drugs / Neurosurgical Anesthesia / Patient Safety / Technology / Equipment / Monitoring / Articles
Articles   |   October 2018
Anesthesia Patient Safety Foundation Panel on Neuromuscular Blockade and Patient Safety: ‘Assessing and Analyzing the Perceptions of Perioperative Professionals on Neuromuscular Blockade and Residual Neuromuscular Paralysis’
ASA Monitor 10 2018, Vol.82, 52-54.
ASA Monitor 10 2018, Vol.82, 52-54.
The Anesthesia Patient Safety Foundation (APSF) presented a panel on neuromuscular blockade and patient safety during ANESTHESIOLOGY 2017 in Boston. The panel included presentation of a survey that sought to determine key clinical and patient safety issues related to perioperative management of neuromuscular blockade. This patient safety initiative was introduced by APSF President Mark Warner, M.D. He presented the project (made possible by an unrestricted grant from Merck, Inc.), which was designed to assess clinicians’ perceptions of neuromuscular blockade monitoring and incidence and management of residual neuromuscular paralysis. It was supported by Dr. Thomas Miller, head of the ASA’s Department of Analytics and Research Services.
0 Comments
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Name
Affiliation & Institution
I have a potential conflict of interest
Comment Title
Comment


This feature is available to Subscribers Only
ASA Member Login or Create an Account ×